119 results on '"Rausch I"'
Search Results
2. Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [68Ga]Ga-PSMA-11 PET/MRI
- Author
-
Papp, L., Spielvogel, C. P., Grubmüller, B., Grahovac, M., Krajnc, D., Ecsedi, B., Sareshgi, R. A.M., Mohamad, D., Hamboeck, M., Rausch, I., Mitterhauser, M., Wadsak, W., Haug, A. R., Kenner, L., Mazal, P., Susani, M., Hartenbach, S., Baltzer, P., Helbich, T. H., Kramer, G., Shariat, S.F., Beyer, T., Hartenbach, M., and Hacker, M.
- Published
- 2021
- Full Text
- View/download PDF
3. 32nd International Austrian Winter Symposium : Zell am See, the Netherlands. 20-23 January 2016.
- Author
-
Langsteger, W, Rezaee, A, Loidl, W, Geinitz, HS, Fitz, F, Steinmair, M, Broinger, G, Pallwien-Prettner, L, Beheshti, M, Imamovic, L, Rendl, G, Hackl, D, Tsybrovsky, O, Emmanuel, K, Moinfar, F, Pirich, C, Bytyqi, A, Karanikas, G, Mayerhöfer, M, Koperek, O, Niederle, B, Hartenbach, M, Beyer, T, Herrmann, K, Czernin, J, Rausch, I, Rust, P, DiFranco, MD, Lassen, M, Stadlbauer, A, Mayerhöfer, ME, Hacker, M, Binzel, K, Magnussen, R, Wei, W, Knopp, MU, Flanigan, DC, Kaeding, C, Knopp, MV, Leisser, A, Nejabat, M, Kramer, G, Krainer, M, Haug, A, Lehnert, Wencke, Schmidt, Karl, Kimiaei, Sharok, Bronzel, Marcus, Kluge, Andreas, Wright, CL, Zhang, J, Wuthrick, Evan, Maniawski, Piotr, Blaickner, M, Rados, E, Huber, A, Dulovits, M, Kulkarni, H, Wiessalla, S, Schuchardt, C, Baum, RP, Knäusl, B, Georg, D, Bauer, M, Wulkersdorfer, B, Wadsak, W, Philippe, C, Haslacher, H, Zeitlinger, M, Langer, O, Feldmann, M, Karch, R, Koepp, MJ, Asselin, M-C, Pataraia, E, Zeilinger, M, Dumanic, M, Pichler, F, Pilz, J, Mitterhauser, M, Nics, L, and Steiner, B
- Subjects
Medical Biochemistry and Metabolomics ,Clinical Sciences ,Oncology and Carcinogenesis - Abstract
Table of contentsA1 68Ga-PSMA PET/CT in staging and restaging of Prostate Cancer Patients: comparative study with 18F-Choline PET/CTW Langsteger, A Rezaee, W Loidl, HS Geinitz, F Fitz, M Steinmair, G Broinger, L Pallwien-Prettner, M BeheshtiA2 F18 Choline PET - CT: an accurate diagnostic tool for the detection of parathyroid adenoma?L Imamovic, M Beheshti, G Rendl, D Hackl, O Tsybrovsky, M Steinmair, K Emmanuel, F Moinfar, C Pirich, W LangstegerA3 [18F]Fluoro-DOPA-PET/CT in the primary diagnosis of medullary thyroid carcinomaA Bytyqi, G Karanikas, M Mayerhöfer, O Koperek, B Niederle, M HartenbachA4 Variations of clinical PET/MR operations: An international survey on the clinical utilization of PET/MRIT Beyer, K Herrmann, J CzerninA5 Standard Dixon-based attenuation correction in combined PET/MRI: Reproducibility and the possibility of Lean body mass estimationI Rausch, P Rust, MD DiFranco, M Lassen, A Stadlbauer, ME Mayerhöfer, M Hartenbach, M Hacker, T BeyerA6 High resolution digital FDG PET/MRI imaging for assessment of ACL graft viabilityK Binzel, R Magnussen, W Wei, MU Knopp, DC Flanigan, C Kaeding, MV KnoppA7 Using pre-existing hematotoxicity as predictor for severe side effects and number of treatment cycles of Xofigo therapyA Leisser, M Nejabat, M Hartenbach, G Kramer, M Krainer, M Hacker, A HaugA8 QDOSE - comprehensive software solution for internal dose assessmentWencke Lehnert, Karl Schmidt, Sharok Kimiaei, Marcus Bronzel, Andreas KlugeA9 Clinical impact of Time-of-Flight on next-generation digital PET imaging of Yttrium-90 radioactivity following liver radioembolizationCL Wright, K Binzel, J Zhang, Evan Wuthrick, Piotr Maniawski, MV KnoppA10 Snakes in patients! Lessons learned from programming active contours for automated organ segmentationM Blaickner, E Rados, A Huber, M Dulovits, H Kulkarni, S Wiessalla, C Schuchardt, RP Baum, B Knäusl, D GeorgA11 Influence of a genetic polymorphism on brain uptake of the dual ABCB1/ABCG2 substrate [11C]tariquidarM Bauer, B Wulkersdorfer, W Wadsak, C Philippe, H Haslacher, M Zeitlinger, O LangerA12 Outcome prediction of temporal lobe epilepsy surgery from P-glycoprotein activity. Pooled analysis of (R)-[11C]-verapamil PET data from two European centresM Bauer, M Feldmann, R Karch, W Wadsak, M Zeitlinger, MJ Koepp, M-C Asselin, E Pataraia, O LangerA13 In-vitro and in-vivo characterization of [18F]FE@SNAP and derivatives for the visualization of the melanin concentrating hormone receptor 1M Zeilinger, C Philippe, M Dumanic, F Pichler, J Pilz, M Hacker, W Wadsak, M MitterhauserA14 Reducing time in quality control leads to higher specific radioactivity of short-lived radiotracersL Nics, B Steiner, M Hacker, M Mitterhauser, W WadsakA15 In vitro 11C-erlotinib binding experiments in cancer cell lines with epidermal growth factor receptor mutationsA Traxl, Thomas Wanek, Kushtrim Kryeziu, Severin Mairinger, Johann Stanek, Walter Berger, Claudia Kuntner, Oliver LangerA16 7-[11C]methyl-6-bromopurine, a PET tracer to measure brain Mrp1 function: radiosynthesis and first PET evaluation in miceS Mairinger, T Wanek, A Traxl, M Krohn, J Stanek, T Filip, M Sauberer, C Kuntner, J Pahnke, O LangerA17 18F labeled azidoglucose derivatives as "click" agents for pretargeted PET imagingD Svatunek, C Denk, M Wilkovitsch, T Wanek, T Filip, C Kuntner-Hannes, J Fröhlich, H MikulaA18 Bioorthogonal tools for PET imaging: development of radiolabeled 1,2,4,5-TetrazinesC Denk, D Svatunek, T Wanek, S Mairinger, J Stanek, T Filip, J Fröhlich, H Mikula, C Kuntner-HannesA19 Preclinical evaluation of [18F]FE@SUPPY- a new PET-tracer for oncologyT Balber, J Singer, J Fazekas, C Rami-Mark, N Berroterán-Infante, E Jensen-Jarolim, W Wadsak, M Hacker, H Viernstein, M MitterhauserA20 Investigation of Small [18F]-Fluoroalkylazides for Rapid Radiolabeling and In Vivo Click ChemistryC Denk, D Svatunek, B Sohr, H Mikula, J Fröhlich, T Wanek, C Kuntner-Hannes, T FilipA21 Microfluidic 68Ga-radiolabeling of PSMA-HBED-CC using a flow-through reactorS Pfaff, C Philippe, M Mitterhauser, M Hartenbach, M Hacker, W WadsakA22 Influence of 24-nor-ursodeoxycholic acid on hepatic disposition of [18F]ciprofloxacin measured with positron emission tomographyT Wanek, E Halilbasic, M Visentin, S Mairinger, B Stieger, C Kuntner, M Trauner, O LangerA23 Automated 18F-flumazenil production using chemically resistant disposable cassettesP Lam, M Aistleitner, R Eichinger, C ArtnerA24 Similarities and differences in the synthesis and quality control of 177Lu-DOTA-TATE, 177Lu -HA-DOTA-TATE and 177Lu-DOTA-PSMA (PSMA-617)H Eidherr, C Vraka, A Haug, M Mitterhauser, L Nics, M Hartenbach, M Hacker, W WadsakA25 68Ga- and 177Lu-labelling of PSMA-617H Kvaternik, R Müller, D Hausberger, C Zink, RM AignerA26 Radiolabelling of liposomes with 67Ga and biodistribution studies after administration by an aerosol inhalation systemU Cossío, M Asensio, A Montes, S Akhtar, Y te Welscher, R van Nostrum, V Gómez-Vallejo, J LlopA27 Fully automated quantification of DaTscan SPECT: Integration of age and gender differencesF VandeVyver, T Barclay, N Lippens, M TrochA28 Lesion-to-background ratio in co-registered 18F-FET PET/MR imaging - is it a valuable tool to differentiate between low grade and high grade brain tumor?L Hehenwarter, B Egger, J Holzmannhofer, M Rodrigues-Radischat, C PirichA29 [11C]-methionine PET in gliomas - a retrospective data analysis of 166 patientsN Pötsch, I Rausch, D Wilhelm, M Weber, J Furtner, G Karanikas, A Wöhrer, M Mitterhauser, M Hacker, T Traub-WeidingerA30 18F-Fluorocholine versus 18F-Fluorodeoxyglucose for PET/CT imaging in patients with relapsed or progressive multiple myeloma: a pilot studyT Cassou-Mounat, S Balogova, V Nataf, M Calzada, V Huchet, K Kerrou, J-Y Devaux, M Mohty, L Garderet, J-N TalbotA31 Prognostic benefit of additional SPECT/CT in sentinel lymph node mapping of breast cancer patientsS Stanzel, G Pregartner, T Schwarz, V Bjelic-Radisic, B Liegl-Atzwanger, R AignerA32 Evaluation of diagnostic value of TOF-18F-FDG PET/CT in patients with suspected pancreatic cancerS Stanzel, F Quehenberger, RM AignerA33 New quantification method for diagnosis of primary hyperpatahyroidism lesions and differential diagnosis vs thyropid nodular disease in dynamic scintigraphyA Koljević Marković, Milica Janković, V Miler Jerković, M Paskaš, G Pupić, R Džodić, D PopovićA34 A rare case of diffuse pancreatic involvement in patient with merkel cell carcinoma detected by 18F-FDGMC Fornito, D FamiliariA35 TSH-stimulated 18F-FDG PET/CT in the diagnosis of recurrent/metastatic radioiodine-negative differentiated thyroid carcinomas in patients with various thyroglobuline levelsP Koranda, H Polzerová, I Metelková, L Henzlová, R Formánek, E Buriánková, M KamínekA36 Breast Dose from lactation following I131 treatmentWH Thomson, C LewisA37 A new concept for performing SeHCAT studies with the gamma cameraWH Thomson, J O'Brien, G James, A NotghiA38 Whole body F-18-FDG-PET and tuberculosis: sensitivity compared to x-ray-CTH Huber, I Stelzmüller, R Wunn, M Mandl, F Fellner, B Lamprecht, M GabrielA39 Emerging role 18F-FDG PET-CT in the diagnosis and follow-up of the infection in heartware ventricular assist system (HVAD)MC Fornito, G LeonardiA40 Validation of Poisson resampling softwareWH Thomson, J O'Brien, G JamesA41 Protection of PET nuclear medicine personnel: problems in satisfying dose limit requirementsJ Hudzietzová, J Sabol, M Fülöp.
- Published
- 2016
4. Impact of the Maximum Ring Difference on Image Quality and Noise Characteristics of a Total Body PET/CT Scanner
- Author
-
Schmidt, F. P., additional, Rausch, I., additional, Mannheim, J. G., additional, Linder, P., additional, Will, P., additional, Conti, M., additional, and la Fougère, C., additional
- Published
- 2023
- Full Text
- View/download PDF
5. JS07.4.A Correspondence of glutamine and glycine imaging based on 7T MRSI to amino acid PET
- Author
-
Hangel, G, primary, Rausch, I, additional, Furtner, J, additional, Roetzer-Pejrimovsky, T, additional, Preusser, M, additional, Bogner, W, additional, Rössler, K, additional, Trattnig, S, additional, Traub-Weidinger, T, additional, and Widhalm, G, additional
- Published
- 2022
- Full Text
- View/download PDF
6. Evaluation of different positron range correction implementations in iterative image reconstruction for I-124 PET imaging
- Author
-
Kertesz, H., additional, Conti, M., additional, Panin, V., additional, Cabello, J., additional, Bharkhada, D., additional, Papp, L., additional, Beyer, T., additional, Jentzen, W., additional, Cal-Gonzalez, J., additional, and Rausch, I., additional
- Published
- 2022
- Full Text
- View/download PDF
7. Positron range correction in combination with resolution recovery image reconstruction of [124I]-PET data
- Author
-
Kertesz, H., Conti, M., Panin, V., Cabello, J., Bharkhada, D., Papp, L., Beyer, T., Jentzen, Walter, Cal-Gonzalez, J., Herraiz, J. L., Lopez-Montes, A., and Rausch, I.
- Subjects
Medizin - Abstract
Poster-Abstract
- Published
- 2022
8. Quality control in PET/CT and PET/MRI: results of an EFOMP survey amongst Europe
- Author
-
Reynés-Llompart, G., primary, Zorz, A., additional, Boellaard, R., additional, Jaroslav, P., additional, Matheoud, R., additional, Pike, L., additional, Soret, M., additional, Vandenberghe, S., additional, Dalianis, K., additional, De Almeida, P.M. Dinis, additional, Fabbri, C., additional, Gawel, J., additional, Hadjitheodorou, P., additional, Julyan, P., additional, Kotzasarlidou, M., additional, Lima, T.V.M., additional, O’Doherty, J., additional, Rausch, I., additional, Sanchez-Garcia, M., additional, Sattler, B., additional, Skovorodko, K., additional, Sutov, D., additional, Taher, A., additional, Tosi, G., additional, Valenti, M., additional, and Vanzi, E., additional
- Published
- 2021
- Full Text
- View/download PDF
9. Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [68Ga]Ga-PSMA-11 PET/MRI
- Author
-
Papp, L., primary, Spielvogel, C. P., additional, Grubmüller, B., additional, Grahovac, M., additional, Krajnc, D., additional, Ecsedi, B., additional, Sareshgi, R. A.M., additional, Mohamad, D., additional, Hamboeck, M., additional, Rausch, I., additional, Mitterhauser, M., additional, Wadsak, W., additional, Haug, A. R., additional, Kenner, L., additional, Mazal, P., additional, Susani, M., additional, Hartenbach, S., additional, Baltzer, P., additional, Helbich, T. H., additional, Kramer, G., additional, Shariat, S.F., additional, Beyer, T., additional, Hartenbach, M., additional, and Hacker, M., additional
- Published
- 2020
- Full Text
- View/download PDF
10. Parameterisation of Positron Range Effects in PET/MRI
- Author
-
Berger, A, additional, Rausch, I, additional, Kertesz, H, additional, Herraiz, JL, additional, López-Montes, A, additional, Conti, M, additional, and Beyer, T, additional
- Published
- 2020
- Full Text
- View/download PDF
11. GATE Monte Carlo simulation model of the Symbia Intevo SPECT/CT system
- Author
-
Kertesz, H, additional, Denisova, N, additional, Ondar, M, additional, Cal-Gonzalez, J, additional, Rausch, I, additional, Schaffarich, P, additional, and Beyer, T, additional
- Published
- 2020
- Full Text
- View/download PDF
12. Evaluation of tissue-dependent and spatially-variant positron-range correction for Iodine-124 PET/MR data
- Author
-
Berger, A, additional, Rausch, I, additional, Kersting, D, additional, Beyer, T, additional, Conti, M, additional, and Jentzen, W, additional
- Published
- 2020
- Full Text
- View/download PDF
13. Assessment of the prompt gamma coincidence correction approach using I-124: a phantom study
- Author
-
Jentzen, W, additional, Harshali, B, additional, Hofferber, R, additional, Costa, PF, additional, Wierts, R, additional, Rausch, I, additional, Berger, A, additional, Beyer, T, additional, Conti, M, additional, and Herrmann, K, additional
- Published
- 2020
- Full Text
- View/download PDF
14. A simple multi-modality phantom for simulating radiomic features in PET, CT and MRI
- Author
-
Valladares, A, additional, Beyer, T, additional, Salomon, E, additional, and Rausch, I, additional
- Published
- 2020
- Full Text
- View/download PDF
15. Fuzzy Radiomics: A novel approach to minimize the effects of target delineation on radiomic models
- Author
-
Papp, L, additional, Rausch, I, additional, Hacker, M, additional, and Beyer, T, additional
- Published
- 2019
- Full Text
- View/download PDF
16. Inter-site variability of quality control procedures and NEMA image quality in PET/MRI systems
- Author
-
Valladares, A, additional, Comtat, C, additional, Chalampalakis, Z, additional, Koole, M, additional, Nuyts, J, additional, Boellaard, R, additional, DalToso, L, additional, Marsden, P, additional, MacKewn, J, additional, Poth, S, additional, Solari, E, additional, Ahangari, S, additional, Hansen, AE, additional, Beyer, T, additional, and Rausch, I, additional
- Published
- 2019
- Full Text
- View/download PDF
17. A head coil system with an integrated orbiting transmission point source mechanism for attenuation correction in PET/MRI
- Author
-
Renner, A, primary, Rausch, I, additional, Cal Gonzalez, J, additional, Frass-Kriegl, R, additional, Navarro de Lara, L I, additional, Sieg, J, additional, Laistler, E, additional, Glanzer, M, additional, Dungl, D, additional, Moser, E, additional, Beyer, T, additional, Figl, M, additional, and Birkfellner, W, additional
- Published
- 2018
- Full Text
- View/download PDF
18. OL48 - Quality control in PET/CT and PET/MRI: results of an EFOMP survey amongst Europe
- Author
-
Reynés-Llompart, G., Zorz, A., Boellaard, R., Jaroslav, P., Matheoud, R., Pike, L., Soret, M., Vandenberghe, S., Dalianis, K., De Almeida, P.M. Dinis, Fabbri, C., Gawel, J., Hadjitheodorou, P., Julyan, P., Kotzasarlidou, M., Lima, T.V.M., O’Doherty, J., Rausch, I., Sanchez-Garcia, M., Sattler, B., Skovorodko, K., Sutov, D., Taher, A., Tosi, G., Valenti, M., and Vanzi, E.
- Published
- 2021
- Full Text
- View/download PDF
19. Quality control for quantitative multicenter whole-body PET/MR studies : A NEMA image quality phantom study with three current PET/MR systems
- Author
-
Boellaard, R., Rausch, I., Beyer, T., Delso, G., Yaqub, M., Quick, H.H., Sattler, B., Radiology and nuclear medicine, CCA - Disease profiling, and NCA - Brain imaging technology
- Subjects
Medizin - Published
- 2015
20. EP-1860: PET/MR in radiation oncology – how to correct for attenuation caused by flat table top?
- Author
-
Andrzejewski, P., primary, Witoszynskyj, S., additional, Rausch, I., additional, Hacker, M., additional, Georg, D., additional, and Knäusl, B., additional
- Published
- 2016
- Full Text
- View/download PDF
21. Variation of system performance, quality control standards and adherence to international FDG-PET/CT imaging guidelines
- Author
-
Bergmann, H., primary, Geist, B., primary, Schaffarich, M., primary, Hirtl, A., primary, Hacker, M., primary, Beyer, T., primary, and Rausch, I., additional
- Published
- 2014
- Full Text
- View/download PDF
22. Influence of PET reconstruction para meters on the TrueX algorithm
- Author
-
Rausch, I. F., primary, Bergmann, H., primary, Dudczak, R., primary, Hirtl, A., primary, Georg, D., primary, and Knäusl, B., additional
- Published
- 2013
- Full Text
- View/download PDF
23. PD-0083 IMPACT OF PET RECONSTRUCTION SETTINGS FOR QUANTIFICATION AND DELINEATION OF LUNG LESIONS IN RADIOTHERAPY
- Author
-
Rausch, I., primary, Knäusl, B., additional, Hirtl, A., additional, Bergmann, H., additional, Dudczak, R., additional, and Georg, D., additional
- Published
- 2012
- Full Text
- View/download PDF
24. 217 INVESTIGATION OF THE INFLUENCE OF DIFFERENT FILTER SETTINGS AND PERMUTATIONS OF ITERATIONS AND SUBSETS ON THE TRUEX ALGORITHM IN POSITRON EMISSION TOMOGRAPHY
- Author
-
Rausch, I., primary, Knäusl, B., additional, Hirtl, A., additional, Bergmann, H., additional, Dudczak, R., additional, and Georg, D., additional
- Published
- 2012
- Full Text
- View/download PDF
25. Gydymas elektroimpulsine terapija.
- Author
-
Venciūtė-Rausch, I., Danilevičiūtė, V., and Navickas, A.
- Subjects
- *
ELECTROCONVULSIVE therapy , *MUSCLE relaxants , *PSYCHOSES , *MENTAL depression , *SCHIZOPHRENIA , *PARKINSON'S disease , *NEUROLEPTIC malignant syndrome - Abstract
Electroconvulsive therapy (ECT) involves the induction of a seizure for therapeutic purposes by the administration of a variable frequency electrical stimulus to the brain via electrodes applied to the scalp. This is the oldest still available somatic treatment in psychiatry. The procedure is ad ministered with muscle relaxants and short acting an esthetics. The clinical literature demonstrating the short term efficacy of ECT in the affective and psychotic disorders is considerable. Approximately 85% of patients currently receiving ECT have major depression as the diagnostic indication, in which ECT is the most effective treatment. The remainders have schizoaffective disorders, mania, and schizophrenia. There are few other diagnoses such as Parkinson's disease, Neuroleptic malignant syndrome, and intractable seizure disorder, completing the inventory of indications. ECT treatment for these indications is supported by case reports only and applied when standard treatments fail. ECT is generally low risk and one of the safest procedures performed under general anesthesia. The estimated risk of serious complications (1 in 1000 patients) is similar to that of general anesthesia for minor medical procedures. Neurocognitive adverse effects are common complications limiting the use of ETC. However, they are mostly mild, improving with time and can be minimized by administering modern modifications of ECT. Despite its proven efficacy and safety, ECT is indicated as the second, third or fourth choice of treatment or as a last attempt to be considered when all others have failed. [ABSTRACT FROM AUTHOR]
- Published
- 2012
26. Parameterisation of Positron Range Effects in PET/MRI.
- Author
-
Berger, A, Rausch, I, Kertesz, H, Herraiz, JL, López-Montes, A, Conti, M, and Beyer, T
- Published
- 2020
- Full Text
- View/download PDF
27. Variation of system performance, quality control standards and adherence to international FDG-PET/CT imaging guidelines
- Author
-
Rausch, I., Bergmann, H., Geist, B., Schaffarich, M., Hirtl, A., Hacker, M., and Beyer, T.
- Published
- 2014
- Full Text
- View/download PDF
28. Influence of PET reconstruction para meters on the TrueX algorithm
- Author
-
Knäusl, B., Rausch, I. F., Bergmann, H., Dudczak, R., Hirtl, A., and Georg, D.
- Published
- 2013
- Full Text
- View/download PDF
29. A simple multi-modality phantom for simulating radiomic features in PET, CT and MRI.
- Author
-
Valladares, A, Beyer, T, Salomon, E, and Rausch, I
- Published
- 2020
- Full Text
- View/download PDF
30. GATE Monte Carlo simulation model of the Symbia Intevo SPECT/CT system.
- Author
-
Kertesz, H, Denisova, N, Ondar, M, Cal-Gonzalez, J, Rausch, I, Schaffarich, P, and Beyer, T
- Published
- 2020
- Full Text
- View/download PDF
31. Assessment of the prompt gamma coincidence correction approach using I-124: a phantom study.
- Author
-
Jentzen, W, Harshali, B, Hofferber, R, Costa, PF, Wierts, R, Rausch, I, Berger, A, Beyer, T, Conti, M, and Herrmann, K
- Published
- 2020
- Full Text
- View/download PDF
32. Evaluation of tissue-dependent and spatially-variant positron-range correction for Iodine-124 PET/MR data.
- Author
-
Berger, A, Rausch, I, Kersting, D, Beyer, T, Conti, M, and Jentzen, W
- Published
- 2020
- Full Text
- View/download PDF
33. 32nd International Austrian Winter Symposium
- Author
-
Langsteger, W, Rezaee, A, Loidl, W, Geinitz, HS, Fitz, F, Steinmair, M, Broinger, G, Pallwien-Prettner, L, Beheshti, M, Imamovic, L, Rendl, G, Hackl, D, Tsybrovsky, O, Emmanuel, K, Moinfar, F, Pirich, C, Bytyqi, A, Karanikas, G, Mayerhöfer, M, Koperek, O, Niederle, B, Hartenbach, M, Beyer, T, Herrmann, K, Czernin, J, Rausch, I, Rust, P, DiFranco, MD, Lassen, M, Stadlbauer, A, Mayerhöfer, ME, Hacker, M, Binzel, K, Magnussen, R, Wei, W, Knopp, MU, Flanigan, DC, Kaeding, C, Knopp, MV, Leisser, A, Nejabat, M, Kramer, G, Krainer, M, Haug, A, Lehnert, Wencke, Schmidt, Karl, Kimiaei, Sharok, Bronzel, Marcus, Kluge, Andreas, Wright, CL, Zhang, J, Wuthrick, Evan, Maniawski, Piotr, Blaickner, M, Rados, E, Huber, A, Dulovits, M, Kulkarni, H, Wiessalla, S, Schuchardt, C, Baum, RP, Knäusl, B, Georg, D, Bauer, M, Wulkersdorfer, B, Wadsak, W, Philippe, C, Haslacher, H, Zeitlinger, M, Langer, O, Feldmann, M, Karch, R, Koepp, MJ, Asselin, M-C, Pataraia, E, Zeilinger, M, Dumanic, M, Pichler, F, Pilz, J, Mitterhauser, M, Nics, L, Steiner, B, Traxl, A, Wanek, Thomas, Kryeziu, Kushtrim, Mairinger, Severin, Stanek, Johann, Berger, Walter, Kuntner, Claudia, Langer, Oliver, Mairinger, S, Wanek, T, Krohn, M, Stanek, J, Filip, T, Sauberer, M, Kuntner, C, Pahnke, J, Svatunek, D, Denk, C, Wilkovitsch, M, Kuntner-Hannes, C, Fröhlich, J, Mikula, H, Balber, T, Singer, J, Fazekas, J, Rami-Mark, C, Berroterán-Infante, N, Jensen-Jarolim, E, Viernstein, H, Sohr, B, Pfaff, S, Halilbasic, E, Visentin, M, Stieger, B, Trauner, M, Lam, P, Aistleitner, M, Eichinger, R, Artner, C, Eidherr, H, Vraka, C, Kvaternik, H, Müller, R, Hausberger, D, Zink, C, Aigner, RM, Cossío, U, Asensio, M, Montes, A, Akhtar, S, te Welscher, Y, van Nostrum, R, Gómez-Vallejo, V, Llop, J, VandeVyver, F, Barclay, T, Lippens, N, Troch, M, Hehenwarter, L, Egger, B, Holzmannhofer, J, Rodrigues-Radischat, M, Pötsch, N, Wilhelm, D, Weber, M, Furtner, J, Wöhrer, A, Traub-Weidinger, T, Cassou-Mounat, T, Balogova, S, Nataf, V, Calzada, M, Huchet, V, Kerrou, K, Devaux, J-Y, Mohty, M, Garderet, L, Talbot, J-N, Stanzel, S, Pregartner, G, Schwarz, T, Bjelic-Radisic, V, Liegl-Atzwanger, B, Aigner, R, Quehenberger, F, Marković, A Koljević, Janković, Milica, Jerković, V Miler, Paskaš, M, Pupić, G, Džodić, R, Popović, D, Fornito, MC, Familiari, D, Koranda, P, Polzerová, H, Metelková, I, Henzlová, L, Formánek, R, Buriánková, E, Kamínek, M, Thomson, WH, Lewis, C, O’Brien, J, James, G, Notghi, A, Huber, H, Stelzmüller, I, Wunn, R, Mandl, M, Fellner, F, Lamprecht, B, Gabriel, M, Leonardi, G, Hudzietzová, J, Sabol, J, and Fülöp, M
- Subjects
urologic and male genital diseases - Abstract
The abstract is available here: https://uscholar.univie.ac.at/o:527627
- Full Text
- View/download PDF
34. Inter-site variability of quality control procedures and NEMA image quality in PET/MRI systems
- Author
-
Valladares, A, Comtat, C, Chalampalakis, Z, Koole, M, Nuyts, J, Boellaard, R, DalToso, L, Marsden, P, MacKewn, J, Poth, S, Solari, E, Ahangari, S, Hansen, AE, Beyer, T, and Rausch, I
- Published
- 2019
- Full Text
- View/download PDF
35. A PET/MRI study on the effect of obesity and NAFLD on hepatic [ 18 F]FDG uptake.
- Author
-
Ustsinau U, Kulterer OC, Rausch I, Krššák M, Kiefer FW, Hacker M, and Philippe C
- Subjects
- Humans, Male, Female, Adult, Middle Aged, Reproducibility of Results, Retrospective Studies, Liver diagnostic imaging, Liver metabolism, Fluorodeoxyglucose F18 pharmacokinetics, Obesity metabolism, Obesity diagnostic imaging, Non-alcoholic Fatty Liver Disease diagnostic imaging, Non-alcoholic Fatty Liver Disease metabolism, Positron-Emission Tomography methods, Radiopharmaceuticals, Magnetic Resonance Imaging methods, Multimodal Imaging methods
- Abstract
Purpose: The potential limitations of hepatic [
18 F]FDG-PET imaging for individuals with obesity and excessive liver fat (NAFLD) are being investigated. In this study, we aim to determine the reliability of standardized uptake values (SUVs) focusing on adjustment for liver fat content (LFC) derived from DIXON images and the effects of whole-body normalizations., Methods: Lean and with obesity volunteers who underwent [18 F]FDG-PET/MRI were reviewed retrospectively. DIXON fat images were used to determine LFC and for adjustment of SUVmean . The hepatic SUVs (mean, fat adjusted mean and max) were normalized to body weight, lean body mass and body surface area. Blood samples were analysed for glucose, serological liver enzymes and lipoproteins for further correlation of [18 F]FDG uptake., Results: Out of 11 volunteers with obesity (M:8, F:3, BMI:30-39 kg/m2 ), 9 confirmed the presence of NAFLD (>5.6 % fat). 22 age-matched lean volunteers (M:10, F:11, BMI:19-26 kg/m2 ) were used as control group. Both SUVmean , before and after adjustment to LFC, did not provide any difference between lean and with obesity groups under BW, LBM and BSA. SUVmax BW showed a difference between groups (p = 0.05). SUVs were independent of levels of GPT, GOT, gGT, insulin, HOMA-IR, triglycerides, cholesterol and LDL. Volunteers with low HDL were clustered with an increased hepatic [18 F]FDG uptake., Conclusion: Our method for adjustment of hepatic [18 F]FDG-PET with DIXON fat images allows to achieve accurate results for individuals with NAFLD and obesity. For homogenic results, raw SUVmean should be combined with adjustment for liver fat, appropriate normalization and consideration of HDL levels., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
36. First-in-human evaluation of 6-bromo-7-[ 11 C]methylpurine, a PET tracer for assessing the function of multidrug resistance-associated proteins in different tissues.
- Author
-
Mairinger S, Jackwerth M, Chalampalakis Z, Rausch I, Weber M, Wölfl-Duchek M, Pracher L, Nics L, Pahnke J, Langsteger W, Hacker M, Zeitlinger M, and Langer O
- Abstract
Purpose: Multidrug resistance-associated protein 1 (MRP1) is a transport protein with a widespread tissue distribution, which has been implicated in the pathophysiology of Alzheimer's and chronic respiratory disease. PET with 6-bromo-7-[
11 C]methylpurine ([11 C]BMP) has been used to measure MRP1 function in rodents. In this study, [11 C]BMP was for the first time characterised in humans to assess the function of MRP1 and other MRP subtypes in different tissues., Methods: Thirteen healthy volunteers (7 men, 6 women) underwent dynamic whole-body PET scans on a long axial field-of-view (LAFOV) PET/CT system after intravenous injection of [11 C]BMP. Three subjects of each sex were scanned a second time to assess reproducibility. Volumes of interest were outlined for MRP-expressing tissues (cerebral cortex, cerebellum, choroid plexus, retina, lungs, myocardium, kidneys, and liver). From the time-activity curves, the elimination rate constant (kE , h- 1 ) was derived as a parameter for tissue MRP function and its test-retest variability (TRTV, %) was calculated. Radiation dosimetry was calculated using the Medical Internal Radiation Dose (MIRD) methodology., Results: Mean kE and corresponding TRTV values were: cerebral cortex: 0.055 ± 0.010 h- 1 (- 4 ± 24%), cerebellum: 0.033 ± 0.009 h- 1 (1 ± 39%), choroid plexus: 0.292 ± 0.059 h- 1 (0.1 ± 16%), retina: 0.234 ± 0.045 h- 1 (30 ± 38%), lungs: 0.875 ± 0.095 h- 1 (- 3 ± 11%), myocardium: 0.641 ± 0.105 h- 1 (11 ± 25%), kidneys: 1.378 ± 0.266 h- 1 (14 ± 16%), and liver: 0.685 ± 0.072 h- 1 (7 ± 9%). Significant sex differences were found for kE in the cerebellum, lungs and kidneys. Effective dose was 4.67 ± 0.18 µSv/MBq for men and 4.55 ± 0.18 µSv/MBq for women., Conclusion: LAFOV PET/CT with [11 C]BMP potentially allows for simultaneous assessment of MRP function in multiple human tissues. Mean TRTV of kE in different tissues was in an acceptable range, except for the retina. The radiation dosimetry of [11 C]BMP was in the typical range of11 C-tracers. LAFOV PET/CT holds great potential to assess at a whole-body, multi-tissue level molecular targets relevant for drug disposition in humans., Trial Registration: EudraCT 2021-006348-29. Registered 15 December 2021., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF
37. In vivo assessment of safety, biodistribution, and radiation dosimetry of the [ 18 F]Me4FDG PET-radiotracer in adults.
- Author
-
Geist BK, Ramirez JC, Binder P, Einspieler H, Ibeschitz H, Langsteger W, Nics L, Rausch I, Diemling M, Sohlberg A, Hacker M, and Rasul S
- Abstract
Background: Approaches targeting the sodium-glucose cotransporter (SGLT) could represent a promising future therapeutic strategy for numerous oncological and metabolic diseases. In this study, we evaluated the safety, biodistribution and radiation dosimetry of the glucose analogue positron emission tomography (PET) agent [
18 F] labeled alpha-methyl-4-deoxy-4-[18 F]fluoro-D-glucopyranoside ([18 F]Me4FDG) with high sodium-glucose cotransporter and low glucose transporter (GLUT) affinity. For this purpose, five healthy volunteers (1 man, 4 women) underwent multiple whole-body PET/computed tomography (CT) examinations starting with injection and up to 4 h after injection of averaged (2.4 ± 0.1) MBq/kg (range: 2.3-2.5 MBq/kg) administered activity. The PET/CT scans were conducted in 5 separate sessions, blood pressure and temperature were measured, and blood and urine samples were collected before the scans and one hour after injection to assess toxicity. Measurements of [18 F]Me4FDG radioactivity in organs of interest were determined from the PET/CT scans at 5 time points. Internal dosimetry was performed on voxel level using a fast Monte Carlo approach., Results: All studied volunteers could well tolerate the [18 F]Me4FDG and no adverse event was reported. The calculated effective dose was (0.013 ± 0.003) mSv/MBq. The organs with the highest absorbed dose were the kidneys with 0.05 mSv/MBq per kidney. The brain showed almost no uptake. After 60 min, (12 ± 15) % of the administered dose was excreted into the bladder., Conclusion: Featuring an effective dose of only 0.013 ± 0.003 mSv/MBq and no occurrence of side effects, the glucose analogue [18 F]Me4FDG seems to be a safe radio-tracer with a favorable biodistribution for PET imaging and also within several consecutive scans., Trial Registration Number: NCT03557138, Registered 22 February 2017, https://ichgcp.net/clinical-trials-registry/NCT03557138 ., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF
38. St. John's wort extract with a high hyperforin content does not induce P-glycoprotein activity at the human blood-brain barrier.
- Author
-
El Biali M, Wölfl-Duchek M, Jackwerth M, Mairinger S, Weber M, Bamminger K, Poschner S, Rausch I, Schindler N, Lozano IH, Jäger W, Nics L, Tournier N, Hacker M, Zeitlinger M, Bauer M, and Langer O
- Subjects
- Humans, Male, Adult, Female, Young Adult, ATP Binding Cassette Transporter, Subfamily B, Member 1 metabolism, ATP Binding Cassette Transporter, Subfamily B metabolism, Bridged Bicyclo Compounds pharmacology, Bridged Bicyclo Compounds pharmacokinetics, Bridged Bicyclo Compounds administration & dosage, Terfenadine pharmacokinetics, Terfenadine administration & dosage, Terfenadine pharmacology, Cytochrome P-450 Enzyme System metabolism, Healthy Volunteers, Hypericum chemistry, Blood-Brain Barrier metabolism, Blood-Brain Barrier drug effects, Phloroglucinol pharmacokinetics, Phloroglucinol pharmacology, Phloroglucinol analogs & derivatives, Phloroglucinol administration & dosage, Plant Extracts pharmacology, Plant Extracts administration & dosage, Plant Extracts pharmacokinetics, Positron-Emission Tomography methods, Terpenes pharmacology, Terpenes pharmacokinetics, Terpenes metabolism, Terfenadine analogs & derivatives
- Abstract
St. John's wort (SJW) extract, a herbal medicine with antidepressant effects, is a potent inducer of intestinal and/or hepatic cytochrome P450 (CYP) enzymes and P-glycoprotein (P-gp), which can cause clinically relevant drug interactions. It is currently not known whether SJW can also induce P-gp activity at the human blood-brain barrier (BBB), which may potentially lead to decreased brain exposure and efficacy of certain central nervous system (CNS)-targeted P-gp substrate drugs. In this study, we used a combination of positron emission tomography (PET) imaging and cocktail phenotyping to gain a comprehensive picture on the effect of SJW on central and peripheral P-gp and CYP activities. Before and after treatment of healthy volunteers (n = 10) with SJW extract with a high hyperforin content (3-6%) for 12-19 days (1800 mg/day), the activity of P-gp at the BBB was assessed by means of PET imaging with the P-gp substrate [
11 C]metoclopramide and the activity of peripheral P-gp and CYPs was assessed by administering a low-dose phenotyping cocktail (caffeine, omeprazole, dextromethorphan, and midazolam or fexofenadine). SJW significantly increased peripheral P-gp, CYP3A, and CYP2C19 activity. Conversely, no significant changes in the peripheral metabolism, brain distribution, and P-gp-mediated efflux of [11 C]metoclopramide across the BBB were observed following the treatment with SJW extract. Our data suggest that SJW does not lead to significant P-gp induction at the human BBB despite its ability to induce peripheral P-gp and CYPs. Simultaneous intake of SJW with CNS-targeted P-gp substrate drugs is not expected to lead to P-gp-mediated drug interactions at the BBB., (© 2024 The Authors. Clinical and Translational Science published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics.)- Published
- 2024
- Full Text
- View/download PDF
39. Direct Patlak Reconstruction of [ 68 Ga]Ga-PSMA PET for the Evaluation of Primary Prostate Cancer Prior Total Prostatectomy: Results of a Pilot Study.
- Author
-
Rasul S, Geist BK, Einspieler H, Fajkovic H, Shariat SF, Schmitl S, Mitterhauser M, Bartosch R, Langsteger W, Baltzer PAT, Beyer T, Ferrara D, Haug AR, Hacker M, and Rausch I
- Abstract
To investigate the use of kinetic parameters derived from direct Patlak reconstructions of [
68 Ga]Ga-PSMA-11 positron emission tomography/computed tomography (PET/CT) to predict the histological grade of malignancy of the primary tumor of patients with prostate cancer (PCa). Thirteen patients (mean age 66 ± 10 years) with a primary, therapy-naïve PCa (median PSA 9.3 [range: 6.3-130 µg/L]) prior radical prostatectomy, were recruited in this exploratory prospective study. A dynamic whole-body [68 Ga]Ga-PSMA-11 PET/CT scan was performed for all patients. Measured quantification parameters included Patlak slope (Ki: absolute rate of tracer consumption) and Patlak intercept (Vb: degree of tracer perfusion in the tumor). Additionally, the mean and maximum standardized uptake values (SUVmean and SUVmax) of the tumor were determined from a static PET 60 min post tracer injection. In every patient, initial PSA (iPSA) values that were also the PSA level at the time of the examination and final histology results with Gleason score (GS) grading were correlated with the quantitative readouts. Collectively, 20 individual malignant prostate lesions were ascertained and histologically graded for GS with ISUP classification. Six lesions were classified as ISUP 5, two as ISUP 4, eight as ISUP 3, and four as ISUP 2. In both static and dynamic PET/CT imaging, the prostate lesions could be visually distinguished from the background. The average values of the SUVmean, slope, and intercept of the background were 2.4 (±0.4), 0.015 1/min (±0.006), and 52% (±12), respectively. These were significantly lower than the corresponding parameters extracted from the prostate lesions (all p < 0.01). No significant differences were found between these values and the various GS and ISUP (all p > 0.05). Spearman correlation coefficient analysis demonstrated a strong correlation between static and dynamic PET/CT parameters (all r ≥ 0.70, p < 0.01). Both GS and ISUP grading revealed only weak correlations with the mean and maximum SUV and tumor-to-background ratio derived from static images and dynamic Patlak slope. The iPSA demonstrated no significant correlation with GS and ISUP grading or with dynamic and static PET parameter values. In this cohort of mainly high-risk PCa, no significant correlation between [68 Ga]Ga-PSMA-11 perfusion and consumption and the aggressiveness of the primary tumor was observed. This suggests that the association between SUV values and GS may be more distinctive when distinguishing clinically relevant from clinically non-relevant PCa.- Published
- 2023
- Full Text
- View/download PDF
40. Feasibility of dose reduction for [18F]FDG-PET/MR imaging of patients with non-lesional epilepsy.
- Author
-
Kertész H, Traub-Weidinger T, Cal-Gonzalez J, Rausch I, Muzik O, Shyiam Sundar LK, and Beyer T
- Subjects
- Humans, Drug Tapering, Feasibility Studies, Positron-Emission Tomography, Magnetic Resonance Imaging, Algorithms, Fluorodeoxyglucose F18, Epilepsy diagnostic imaging
- Abstract
The aim of the study was to evaluate the effect of reduced injected [18F]FDG activity levels on the quantitative and diagnostic accuracy of PET images of patients with non-lesional epilepsy (NLE).Nine healthy volunteers and nine patients with NLE underwent 60-min dynamic list-mode (LM) scans on a fully-integrated PET/MRI system. Injected FDG activity levels were reduced virtually by randomly removing counts from the last 10-min of the LM data, so as to simulate the following activity levels: 50 %, 35 %, 20 %, and 10 % of the original activity. Four image reconstructions were evaluated: standard OSEM, OSEM with resolution recovery (PSF), the A-MAP, and the Asymmetrical Bowsher (AsymBowsher) algorithms. For the A-MAP algorithms, two weights were selected (low and high). Image contrast and noise levels were evaluated for all subjects while the lesion-to-background ratio (L/B) was only evaluated for patients. Patient images were scored by a Nuclear Medicine physician on a 5-point scale to assess clinical impression associated with the various reconstruction algorithms.The image contrast and L/B ratio characterizing all four reconstruction algorithms were similar, except for reconstructions based on only 10 % of total counts. Based on clinical impression, images with diagnostic quality can be achieved with as low as 35 % of the standard injected activity. The selection of algorithms utilizing an anatomical prior did not provide a significant advantage for clinical readings, despite a small improvement in L/B (< 5 %) using the A-MAP and AsymBowsher reconstruction algorithms.In patients with NLE who are undergoing [18F]FDG-PET/MR imaging, the injected [18F]FDG activity can be reduced to 35 % of the original dose levels without compromising., Competing Interests: The authors declare that they have no conflict of interest., (Thieme. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
41. Characterization of the partial volume effect along the axial field-of-view of the Biograph Vision Quadra total-body PET/CT system for multiple isotopes.
- Author
-
Mannheim JG, Rausch I, Conti M, la Fougère C, and Schmidt FP
- Abstract
Background: Total-body PET scanners with axial field of views (FOVs) longer than 1 m enable new applications to study multiple organs (e.g., the brain-gut-axis) simultaneously. As the spatial resolution and the associated partial volume effect (PVE) can vary significantly along the FOV, detailed knowledge of the contrast recovery coefficients (CRCs) is a prerequisite for image analysis and interpretation of quantitative results. The aim of this study was to determine the CRCs, as well as voxel noise, for multiple isotopes throughout the 1.06 m axial FOV of the Biograph Vision Quadra PET/CT system (Siemens Healthineers)., Materials and Methods: Cylindrical phantoms equipped with three different sphere sizes (inner diameters 7.86 mm, 28 and 37 mm) were utilized for the PVE evaluation. The 7.86 mm sphere was filled with F-18 (8:1 and 4:1), Ga-68 (8:1) and Zr-89 (8:1). The 28 mm and 37 mm spheres were filled with F-18 (8:1). Background concentration in the respective phantoms was of ~ 3 kBq/ml. The phantoms were measured at multiple positions in the FOV (axial: 0, 10, 20, 30, 40 and 50 cm, transaxial: 0, 10, 20 cm). The data were reconstructed with the standard clinical protocol, including PSF correction and TOF information with up to 10 iterations for maximum ring differences (MRDs) of 85 and 322; CRCs, as well as voxel noise levels, were determined for each position., Results: F-18 CRCs (SBR 8:1 and 4:1) of the 7.86 mm sphere decreased up to 18% from the center FOV (cFOV) toward the transaxial edge and increased up to 17% toward the axial edge. Noise levels were below 15% for the default clinical reconstruction parameters. The larger spheres exhibited a similar pattern. Zr-89 revealed ~ 10% lower CRCs than F-18 but larger noise (9.1% (F-18), 19.1% (Zr-89); iteration 4, cFOV) for the default reconstruction. Zr-89 noise levels in the cFOV significantly decreased (~ 28%) when reconstructing the data with MRD322 compared with MRD85 along with a slight decrease in CRC values. Ga-68 exhibited the lowest CRCs for the three isotopes and noise characteristics comparable to those of F-18., Conclusions: Distinct differences in the PVE within the FOV were detected for clinically relevant isotopes F-18, Ga-68 and Zr-89, as well as for different sphere sizes. Depending on the positions inside the FOV, the sphere-to-background ratios, count statistics and isotope used, this can result in an up to 50% difference between CRCs. Hence, these changes in PVE can significantly affect the quantitative analysis of patient data. MRD322 resulted in slightly lower CRC values, especially in the center FOV, whereas the voxel noise significantly decreased compared with MRD85., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
42. Evaluation of Gliomas with Magnetic Resonance Fingerprinting with PET Correlation-A Comparative Study.
- Author
-
Marik W, Cardoso PL, Springer E, Bogner W, Preusser M, Widhalm G, Hangel G, Hainfellner JA, Rausch I, Weber M, Schmidbauer V, Traub-Weidinger T, and Trattnig S
- Abstract
Objectives: Advanced MR imaging of brain tumors is still mainly based on qualitative imaging. PET imaging offers additive metabolic information, and MR fingerprinting (MRF) offers a novel approach to quantitative data acquisition. The purpose of this study was to evaluate the ability of MRF to predict tumor regions and grading in combination with PET., Methods: Seventeen patients with histologically verified infiltrating gliomas and available amino-acid PET data were enrolled. ROIs for solid tumor parts (SPo), perifocal edema (ED1), and normal-appearing white matter (NAWM) were selected on conventional MRI sequences and aligned to the MRF and PET images. The predictability of gliomas by region and grading as well as intermodal correlations were assessed., Results: For MRF, we calculated an overall predictability by region (SPo, ED1, and NAWM) for all of the MRF parameters of 76.5%, 47.1%, and 94.1%, respectively. The overall ability to distinguish low- from high-grade gliomas using MRF was 88.9% for LGG and 75% for HGG, with an accuracy of 82.4%, a ppV of 85.71%, and an npV of 80%. PET positivity was found in 13/17 patients for solid tumor parts, and in 3/17 patients for the edema region. However, there was no significant difference in region-specific MRF values between PET positive and PET negative patients., Conclusions: MRF and PET provide quantitative measurements of the tumor tissue characteristics of gliomas, with good predictability. Nonetheless, the results are dissimilar, reflecting the different underlying mechanisms of each method.
- Published
- 2023
- Full Text
- View/download PDF
43. Whole-body metabolic connectivity framework with functional PET.
- Author
-
Reed MB, Ponce de León M, Vraka C, Rausch I, Godbersen GM, Popper V, Geist BK, Komorowski A, Nics L, Schmidt C, Klug S, Langsteger W, Karanikas G, Traub-Weidinger T, Hahn A, Lanzenberger R, and Hacker M
- Subjects
- Female, Humans, Brain metabolism, Human Body, Positron-Emission Tomography methods, Male, Young Adult, Adult, Fluorodeoxyglucose F18 metabolism, Positron Emission Tomography Computed Tomography
- Abstract
The nervous and circulatory system interconnects the various organs of the human body, building hierarchically organized subsystems, enabling fine-tuned, metabolically expensive brain-body and inter-organ crosstalk to appropriately adapt to internal and external demands. A deviation or failure in the function of a single organ or subsystem could trigger unforeseen biases or dysfunctions of the entire network, leading to maladaptive physiological or psychological responses. Therefore, quantifying these networks in healthy individuals and patients may help further our understanding of complex disorders involving body-brain crosstalk. Here we present a generalized framework to automatically estimate metabolic inter-organ connectivity utilizing whole-body functional positron emission tomography (fPET). The developed framework was applied to 16 healthy subjects (mean age ± SD, 25 ± 6 years; 13 female) that underwent one dynamic
18 F-FDG PET/CT scan. Multiple procedures of organ segmentation (manual, automatic, circular volumes) and connectivity estimation (polynomial fitting, spatiotemporal filtering, covariance matrices) were compared to provide an optimized thorough overview of the workflow. The proposed approach was able to estimate the metabolic connectivity patterns within brain regions and organs as well as their interactions. Automated organ delineation, but not simplified circular volumes, showed high agreement with manual delineation. Polynomial fitting yielded similar connectivity as spatiotemporal filtering at the individual subject level. Furthermore, connectivity measures and group-level covariance matrices did not match. The strongest brain-body connectivity was observed for the liver and kidneys. The proposed framework offers novel opportunities towards analyzing metabolic function from a systemic, hierarchical perspective in a multitude of physiological pathological states., Competing Interests: Declaration of Competing Interest M. Hacker received consulting fees and/or honoraria from Bayer Healthcare BMS, Eli Lilly, EZAG, GE Healthcare, Ipsen, ITM, Janssen, Roche, and Siemens Healthineers. R. Lanzenberger received travel grants and/or conference speaker honoraria from Bruker BioSpin within the last three years and investigator-initiated research funding from Siemens Healthcare regarding clinical research using PET/MR. He is a shareholder of the start-up company BM Health GmbH since 2019. Ivo Rausch received a research grant from Siemens Healthineers not related to this study. All other authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article., (Copyright © 2023. Published by Elsevier Inc.)- Published
- 2023
- Full Text
- View/download PDF
44. Comparison of cardiac image-derived input functions for quantitative whole body [ 18 F]FDG imaging with arterial blood sampling.
- Author
-
Reed MB, Godbersen GM, Vraka C, Rausch I, Ponce de León M, Popper V, Geist B, Nics L, Komorowski A, Karanikas G, Beyer T, Traub-Weidinger T, Hahn A, Langsteger W, Hacker M, and Lanzenberger R
- Abstract
Introduction: Dynamic positron emission tomography (PET) and the application of kinetic models can provide important quantitative information based on its temporal information. This however requires arterial blood sampling, which can be challenging to acquire. Nowadays, state-of-the-art PET/CT systems offer fully automated, whole-body (WB) kinetic modelling protocols using image-derived input functions (IDIF) to replace arterial blood sampling. Here, we compared the validity of an automatic WB kinetic model protocol to the reference standard arterial input function (AIF) for both clinical and research settings. Methods: Sixteen healthy participants underwent dynamic WB [
18 F]FDG scans using a continuous bed motion PET/CT system with simultaneous arterial blood sampling. Multiple processing pipelines that included automatic and manually generated IDIFs derived from the aorta and left ventricle, with and without motion correction were compared to the AIF. Subsequently generated quantitative images of glucose metabolism were compared to evaluate performance of the different input functions. Results: We observed moderate to high correlations between IDIFs and the AIF regarding area under the curve (r = 0.49-0.89) as well as for the cerebral metabolic rate of glucose (CMRGlu) (r = 0.68-0.95). Manual placing of IDIFs and motion correction further improved their similarity to the AIF. Discussion: In general, the automatic vendor protocol is a feasible approach for the quantification of CMRGlu for both, clinical and research settings where expertise or time is not available. However, we advise on a rigorous inspection of the placement of the volume of interest, the resulting IDIF, and the quantitative values to ensure valid interpretations. In protocols requiring longer scan times or where cohorts are prone to involuntary movement, manual IDIF definition with additional motion correction is recommended, as this has greater accuracy and reliability., Competing Interests: RL received investigator-initiated research funding from Siemens Healthcare regarding clinical research using PET/MR. He is a shareholder of the start-up company BM Health GmbH since 2019. MH received consulting fees and/or honoraria from Bayer Healthcare BMS, Eli Lilly, EZAG, GE Healthcare, Ipsen, ITM, Janssen, Roche, and Siemens Healthineers. IR received a research grant from Siemens Healthineers not related to this study. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The handling editor CC declared a past co-authorship with the authors TB and IR., (Copyright © 2023 Reed, Godbersen, Vraka, Rausch, Ponce de León, Popper, Geist, Nics, Komorowski, Karanikas, Beyer, Traub-Weidinger, Hahn, Langsteger, Hacker and Lanzenberger.)- Published
- 2023
- Full Text
- View/download PDF
45. Sex-specific radiomic features of L-[S-methyl- 11 C] methionine PET in patients with newly-diagnosed gliomas in relation to IDH1 predictability.
- Author
-
Papp L, Rasul S, Spielvogel CP, Krajnc D, Poetsch N, Woehrer A, Patronas EM, Ecsedi B, Furtner J, Mitterhauser M, Rausch I, Widhalm G, Beyer T, Hacker M, and Traub-Weidinger T
- Abstract
Introduction: Amino-acid positron emission tomography (PET) is a validated metabolic imaging approach for the diagnostic work-up of gliomas. This study aimed to evaluate sex-specific radiomic characteristics of L-[S-methyl-
11 Cmethionine (MET)-PET images of glioma patients in consideration of the prognostically relevant biomarker isocitrate dehydrogenase (IDH) mutation status., Methods: MET-PET of 35 astrocytic gliomas (13 females, mean age 41 ± 13 yrs. and 22 males, mean age 46 ± 17 yrs.) and known IDH mutation status were included. All patients underwent radiomic analysis following imaging biomarker standardization initiative (IBSI)-conform guidelines both from standardized uptake value (SUV) and tumor-to-background ratio (TBR) PET values. Aligned Monte Carlo (MC) 100-fold split was utilized for SUV and TBR dataset pairs for both sex and IDH-specific analysis. Borderline and outlier scores were calculated for both sex and IDH-specific MC folds. Feature ranking was performed by R-squared ranking and Mann-Whitney U-test together with Bonferroni correction. Correlation of SUV and TBR radiomics in relation to IDH mutational status in male and female patients were also investigated., Results: There were no significant features in either SUV or TBR radiomics to distinguish female and male patients. In contrast, intensity histogram coefficient of variation (ih.cov) and intensity skewness (stat.skew) were identified as significant to predict IDH +/-. In addition, IDH+ females had significant ih.cov deviation (0.031) and mean stat.skew (-0.327) differences compared to IDH+ male patients (0.068 and -0.123, respectively) with two-times higher standard deviations of the normal brain background MET uptake as well., Discussion: We demonstrated that female and male glioma patients have significantly different radiomic profiles in MET PET imaging data. Future IDH prediction models shall not be built on mixed female-male cohorts, but shall rely on sex-specific cohorts and radiomic imaging biomarkers., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Papp, Rasul, Spielvogel, Krajnc, Poetsch, Woehrer, Patronas, Ecsedi, Furtner, Mitterhauser, Rausch, Widhalm, Beyer, Hacker and Traub-Weidinger.)- Published
- 2023
- Full Text
- View/download PDF
46. EFOMP's protocol quality controls in PET/CT and PET/MR.
- Author
-
Matheoud R, Boellaard R, Pike L, Ptacek J, Reynés-Llompart G, Soret M, Vandenberghe S, Zorz A, Julyan P, Rausch I, Sattler B, Manuel SG, Tosi G, Dalianis K, Almeida PMD, Fabbri C, Gawel J, Hadjitheodorou P, Kotzasarlidou M, Viana Miranda Lima T, O'Doherty J, Skovorodko K, Sutov D, Taher A, Valenti M, and Vanzi E
- Subjects
- Humans, Positron-Emission Tomography methods, Magnetic Resonance Imaging methods, Quality Control, Image Processing, Computer-Assisted methods, Positron Emission Tomography Computed Tomography, Multimodal Imaging methods
- Abstract
This article presents the protocol on Quality Controls in PET/CT and PET/MRI published online in May 2022 by the European Federation of Organisations for Medical Physics (EFOMP), which was developed by the Working group for PET/CT and PET/MRI Quality Control (QC) protocol. The main objective of this protocol was to comprehensively provide simple and practical procedures that may be integrated into clinical practice to identify changes in the PET/CT/MRI system's performance and avoid short- and long-term quality deterioration. The protocol describes the quality control procedures on radionuclide calibrators, weighing scales, PET, CT and MRI systems using selected and measurable parameters that are directly linked to clinical images quality. It helps to detect problems before they can impact clinical studies in terms of safety, image quality, quantification accuracy and patient radiation dose. CT and MRI QCs are described only in the context of their use for PET (attenuation correction and anatomical localization) imaging. Detailed step-by-step instructions have been provided, limiting any misinterpretations or interpersonal variations as much as possible. This paper presents the main characteristics of the protocol illustrated together with a brief summary of the content of each chapter. A regular QC based on the proposed protocol would guarantee that PET/CT and PET/MRI systems operate under optimal conditions, resulting in the best performance for routine clinical tasks., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2022 Associazione Italiana di Fisica Medica e Sanitaria. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
47. Image quality assessment along the one metre axial field-of-view of the total-body Biograph Vision Quadra PET/CT system for 18 F-FDG.
- Author
-
Rausch I, Mannheim JG, Kupferschläger J, la Fougère C, and Schmidt FP
- Abstract
Aim: Recently, total-body PET/CT systems with an extended axial field-of-view (aFOV) became commercially available which allow acquiring physiologic information of multiple organs simultaneously. However, the nominal aFOV may clinically not be used effectively due to the inherently reduced sensitivity at the distal ends of the aFOV. The aim of this study was to assess the extent of the useful aFOV of the Biograph Vision Quadra PET/CT system., Methods: A NEMA image quality (IQ) phantom mimicking a standard [
18 F]FDG examination was used. Image contrast and noise were assessed across the 106 cm aFOV of the Biograph Vision Quadra PET/CT system (Siemens Healthineers). Phantom acquisitions were performed at different axial positions. PET data were rebinned to simulate different acquisition times for a standard injected activity and reconstructed using different filter settings to evaluate the noise and images along the axial direction., Results: Image noise and contrast were stable within the central 80 cm of the aFOV. Outside this central area, image contrast variability as well as image noise increased. This degradation of IQ was in particular evident for short acquisition times of less than 30 s. At 10 min acquisition time and in the absence of post-reconstruction filtering, the useful aFOV was 100 cm. For a 2 min acquisition time, a useful aFOV with image noise below 15% was only achievable using Gaussian filtering with axial extents of between 83 and 103 cm when going from 2 to 6 mm full-width-half-maximum, respectively., Conclusion: Image noise increases substantially towards the ends of the aFOV. However, good IQ in compliance with generally accepted benchmarks is achievable for an aFOV of > 90 cm. When accepting higher image noise or using dedicated protocol settings such as stronger filtering a useful aFOV of around 1 m can be achieved for a 2 min acquisition time., (© 2022. The Author(s).)- Published
- 2022
- Full Text
- View/download PDF
48. Additively manufactured, solid object structures for adjustable image contrast in Magnetic Resonance Imaging.
- Author
-
Valladares A, Oberoi G, Berg A, Beyer T, Unger E, and Rausch I
- Subjects
- Humans, Phantoms, Imaging, Printing, Three-Dimensional, Magnetic Resonance Imaging methods, Neoplasms
- Abstract
The choice of materials challenges the development of Magnetic Resonance Imaging (MRI) phantoms and, to date, is mainly limited to water-filled compartments or gel-based components. Recently, solid materials have been introduced through additive manufacturing (AM) to mimic complex geometrical structures. Nonetheless, no such manufactured solid materials are available with controllable MRI contrast to mimic organ substructures or lesion heterogeneities. Here, we present a novel AM design that allows MRI contrast manipulation by varying the partial volume contribution to a ROI/voxel of MRI-visible material within an imaging object. Two sets of 11 cubes and three replicates of a spherical tumour model were designed and printed using AM. Most samples presented varying MRI-contrast in standard MRI sequences, based mainly on spin density and partial volume signal variation. A smooth and continuous MRI-contrast gradient could be generated in a single-compartment tumour model. This concept supports the development of more complex MRI phantoms that mimic the appearance of heterogeneous tumour tissues., Competing Interests: Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: [The Medical University of Vienna has applied for a patent concerning the building technique of solid objects with variable MRI contrast. Ewald Unger and Ivo Rausch are quoted as inventors. The authors declare that the research was conducted without any further commercial or financial relationships that could be construed as a potential conflict of interest.], (Copyright © 2022. Published by Elsevier GmbH.)
- Published
- 2022
- Full Text
- View/download PDF
49. Impact of ComBat Harmonization on PET Radiomics-Based Tissue Classification: A Dual-Center PET/MRI and PET/CT Study.
- Author
-
Leithner D, Schöder H, Haug A, Vargas HA, Gibbs P, Häggström I, Rausch I, Weber M, Becker AS, Schwartz J, and Mayerhoefer ME
- Subjects
- Humans, Magnetic Resonance Imaging, Positron-Emission Tomography, Retrospective Studies, Fluorodeoxyglucose F18, Positron Emission Tomography Computed Tomography
- Abstract
Our purpose was to determine whether ComBat harmonization improves
18 F-FDG PET radiomics-based tissue classification in pooled PET/MRI and PET/CT datasets. Methods: Two hundred patients who had undergone18 F-FDG PET/MRI (2 scanners and vendors; 50 patients each) or PET/CT (2 scanners and vendors; 50 patients each) were retrospectively included. Gray-level histogram, gray-level cooccurrence matrix, gray-level run-length matrix, gray-level size-zone matrix, and neighborhood gray-tone difference matrix radiomic features were calculated for volumes of interest in the disease-free liver, spleen, and bone marrow. For individual feature classes and a multiclass radiomic signature, tissue was classified on ComBat-harmonized and unharmonized pooled data, using a multilayer perceptron neural network. Results: Median accuracies in training and validation datasets were 69.5% and 68.3% (harmonized), respectively, versus 59.5% and 58.9% (unharmonized), respectively, for gray-level histogram; 92.1% and 86.1% (harmonized), respectively, versus 53.6% and 50.0% (unharmonized), respectively, for gray-level cooccurrence matrix; 84.8% and 82.8% (harmonized), respectively, versus 62.4% and 58.3% (unharmonized), respectively, for gray-level run-length matrix; 87.6% and 85.6% (harmonized), respectively, versus 56.2% and 52.8% (unharmonized), respectively, for gray-level size-zone matrix; 79.5% and 77.2% (harmonized), respectively, versus 54.8% and 53.9% (unharmonized), respectively, for neighborhood gray-tone difference matrix; and 86.9% and 84.4% (harmonized), respectively, versus 62.9% and 58.3% (unharmonized), respectively, for radiomic signature. Conclusion: ComBat harmonization may be useful for multicenter18 F-FDG PET radiomics studies using pooled PET/MRI and PET/CT data., (© 2022 by the Society of Nuclear Medicine and Molecular Imaging.)- Published
- 2022
- Full Text
- View/download PDF
50. Impact of SSTR PET on Inter-Observer Variability of Target Delineation of Meningioma and the Possibility of Using Threshold-Based Segmentations in Radiation Oncology.
- Author
-
Kriwanek F, Ulbrich L, Lechner W, Lütgendorf-Caucig C, Konrad S, Waldstein C, Herrmann H, Georg D, Widder J, Traub-Weidinger T, and Rausch I
- Abstract
Aim: The aim of this study was to assess the effects of including somatostatin receptor agonist (SSTR) PET imaging in meningioma radiotherapy planning by means of changes in inter-observer variability (IOV). Further, the possibility of using threshold-based delineation approaches for semiautomatic tumor volume definition was assessed. Patients and Methods: Sixteen patients with meningioma undergoing fractionated radiotherapy were delineated by five radiation oncologists. IOV was calculated by comparing each delineation to a consensus delineation, based on the simultaneous truth and performance level estimation (STAPLE) algorithm. The consensus delineation was used to adapt a threshold-based delineation, based on a maximization of the mean Dice coefficient. To test the threshold-based approach, seven patients with SSTR-positive meningioma were additionally evaluated as a validation group. Results: The average Dice coefficients for delineations based on MRI alone was 0.84 ± 0.12. For delineation based on MRI + PET, a significantly higher dice coefficient of 0.87 ± 0.08 was found (p < 0.001). The Hausdorff distance decreased from 10.96 ± 11.98 mm to 8.83 ± 12.21 mm (p < 0.001) when adding PET for the lesion delineation. The best threshold value for a threshold-based delineation was found to be 14.0% of the SUVmax, with an average Dice coefficient of 0.50 ± 0.19 compared to the consensus delineation. In the validation cohort, a Dice coefficient of 0.56 ± 0.29 and a Hausdorff coefficient of 27.15 ± 21.54 mm were found for the threshold-based approach. Conclusions: SSTR-PET added to standard imaging with CT and MRI reduces the IOV in radiotherapy planning for patients with meningioma. When using a threshold-based approach for PET-based delineation of meningioma, a relatively low threshold of 14.0% of the SUVmax was found to provide the best agreement with a consensus delineation.
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.